BREAST CANCER

Nearly 40 percent of all breast cancer cases in the United States could be prevented if women kept a healthy weight, drank less alcohol, exercised more and breastfed their babies, according to a report published on Tuesday.

A very low dose of estrogen might help women whose breast cancer has come back after treatment, researchers reported on Tuesday.

Improvements in cancer screening and better treatments have resulted in steady declines in cancer death rates over the past three decades, U.S. researchers said on Thursday.

Receiving a diagnosis of breast cancer is a fear shared by millions of women. It doesn't matter their age, race, ethnicity, or other factors; this is something all women have in common.

A woman with a mother or sister with breast cancer should

Women who have a mastectomy after being diagnosed with breast cancer seem have a similar quality of life in the long term whether they have breast reconstruction surgery or not, a research review suggests.

One of the most aggressive forms of breast cancer may originate in the cells lining the mammary ducts, which can be targeted in the fight against the disease, experts in Australia say.

Later diagnosis and differences in treatment may be among the reasons that African Americans are less likely than whites to survive colon cancer, a study published Monday suggests.

Breastfeeding may protect women with multiple sclerosis against relapses of their disease, possibly by delaying a return to normal monthly cycles, U.S. researchers reported on Monday.

Cancer drug Avastin -- a key Genentech asset now wholly owned by Roche Holding AG -- has failed in a major study to prevent the recurrence of colon cancer in patients who have undergone surgery.

LONDON (Reuters) - The synthetic hormone Livial, designed as an alternative to hormone replacement therapy, makes it significantly more likely a woman's breast cancer will come back, Dutch researchers said on Tuesday.

Drug developer Novartis said on Monday it may offer a novel treatment strategy for patients with breast cancer through its compound RAD001 which enhances the efficacy of treatments or overcomes resistance to some of them.

Merck & Co. reported a Phase III trial which studies odanacatib for the treatment of osteoporosis in postmenopausal woman is underway which will include tests for breast and prostate cancer.

GlaxoSmithKline Plc's breast cancer vaccine was recommended for approval by European drug regulators on Thursday but they warned of potential liver toxicity, according to a report.

An experimental vaccine to spur the immune system to fight breast cancer seemed to reduce the risk of death in a significant number of women, according to a clinical trial monitored by the U.S. military.

The second largest biotechnology company Genentech Inc. reported an increase of 12 percent in its first-quarter profits helped by more sells of its cancer drug Avastin.

Menopausal women who took estrogen and progesterone faced a small increased risk for cancer for more than two years after they stopped taking the pills, researchers said on Tuesday.

Want to walk for a good cause but find yourself strapped for time or physically incapable? Welcome to the virtual walk where you can raise money for charity without ever stepping out the front door.

Dendreon Corp. (Nasdaq: DNDN) said its breast cancer vaccine Neuvenge appeared to be safe, according to results of an initial study.

GlaxoSmithKine plc has announced today the submission of a New Drug Application to the United States Food and Drug Administration (FDA), for approval to market.

German drugmaker Schering has entered into a deal with AstraZeneca to jointly develop a new breast cancer drug